摘要
目的探究与分析造影剂碘普罗胺在妇科盆腔CT检查中的效果及其安全性。方法运用回顾性研究方法,选取我院2018年2月—2021年1月收治的78例接受妇科盆腔CT增强检查者作为研究对象,观测全部患者的影像质量、全身及局部耐受性和相关不良反应。结果在78例检查中,影像质量优良率为97.44%,患者耐受度为97.44%。患者出现恶心呕吐、头晕头痛、局部痛感、面部潮红的轻度不良反应占8.98%;有2例患者分别出现剧烈呕吐和胸闷气促,并伴有全身性皮疹的中度不良反应,给予相应处置后,患者均恢复正常。结论非离子型造影剂碘普罗胺在妇科盆腔CT增强检查中能获得良好的影像质量,碘普罗胺的不良反应发生率低于离子型碘造影剂,但高于其他非离子型造影剂。
Objective To investigate the efficacy and safety of iopromide as a contrast agent in gynecological pelvic CT examination.Methods In a retrospective study,78 patients hospitalized from February 2018 to January 2021 who underwent contrast-enhanced gynecological pelvic CT were involved to investigate the image quality,systemic and local tolerance,and adverse reactions.Results Among the 78 cases,97.44%had excellent image quality and 97.44%showed tolerance.Mild adverse reactions such as nausea and vomiting,dizziness,headache,local pain,and facial flushing occurred in 8.98%cases.Moderate adverse reactions included severe vomiting with generalized rash(one case)and chest tightness and shortness of breath with generalized rash(one case),and both patients returned to normal after treatment.Conclusion The nonionic contrast agent iopromide can be used to obtain good image quality in gynecological pelvic CT examination.The incidence of adverse reactions of iopromide is lower than ionic iodine contrast agents,but higher other non-ionic contrast agents.
作者
魏霆
吴燕平
WEI Ting;WU Yanping(Fujian Maternity and Child Health Hospital,Fuzhou 350005 China)
出处
《中国辐射卫生》
2022年第2期214-218,共5页
Chinese Journal of Radiological Health
关键词
造影剂
碘普罗胺
妇科盆腔
CT
安全性
Contrast agent
Iopromide
Gynecological pelvic cavity
CT
Safety